ARTELO BIOSCIENCES, INC. (ARTL) › Cash & EquivalentsARTELO BIOSCIENCES, INC. (ARTL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2014: $14.7K2015: $17.0K2016: $3.6K2017: $572.8K2018: $337.4K2019: $4.42M2020: $2.14M2021: $12.16M2022: $6.89M2025: $600.0K$600.0K2014Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$600.0K—2022$6.89M-43.4%2021$12.16M+467.8%2020$2.14M-51.6%2019$4.42M+1211.1%2018$337.4K-41.1%2017$572.8K+15854.7%2016$3.6K-78.9%2015$17.0K+15.6%2014$14.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share